Marc Beer Does Everything He Can for Women Suffering from Pelvic Floor Disorders
Marc Beer has always been a generous man. When he worked for Genzyme after college, it was his job to promote the company’s product line. Genzyme was one of the few companies trying to treat the more than 7,000 rare diseases affecting more than 350 million people around the world.
His work at Genzyme inspired him to step up his game and do more by exploring every entrepreneurial option. Eventually, he launched ViaCell, a company that produced solutions developed from collected umbilical cord blood stem cells. In 2007, he sold that company for $300 million and planned to use that money to start up another business.
Tragically, his wife passed away suddenly after the sale. Beer was heartbroken and found solace only in raising his three children. He dedicated all of his time and energy into being a single father, but his daughter wanted more for her dad. Using the advice he gave his children every day, she encouraged him to launch another business and truly live with purpose. Learn more: https://renoviainc.com/leadership/
Around the same time, Dr. Ray Iglesias was looking for a way to help his patients avoid surgery. Dr. Iglesias is a gynecologist who inadvertently specialized in pelvic floor surgeries. The good doctor always believed there was another way to help these women, but he couldn’t figure it out by himself; he needed help, and Marc Beer was just the man to help him.
Along with Yolanda Lorie, the trio founded Renovia. Today, Beer is not only a co-founder but he’s the CEO and Chairman. The Boston-based biotech company is trying to develop therapeutic and diagnostic devices for women with pelvic floor disorders. To Beer, the company will only be successful if they can develop first-line diagnosis and treatment. Despite his immense financial success, it’s never been about money for Beer.
The number of women suffering from pelvic floor disorders is too great for Beer to ignore. According to one study, nearly one-fourth of women living in the United States are affected by these disorders. Pelvic floor disorders can cause pelvic organ prolapsed, urinary incontinence, and fecal incontinence; it’s a serious issue.
Last year, Renovia had its first big break when its first product, Leva, was approved by the FDA. Though Leva is considered a milestone successfully past, Beer won’t be satisfied until he obtains the results he’s looking for: innovative and proprietary sensor technologies and a digital health platform.